| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, October 18, 2022 12:34:40 PM
And yet, it says 5 year survival “analysis”…
And multiple governmental agencies reviewed the data and chose not to fund it for most patients because the benefits were questionable for most patients. The UK only provides it to a narrow band if patients. Washington State went through a whole breakdown.
I’ve posted this stuff before. Plus you have statistical evidence problems that Flipper has gone through in relationship to overly
censoring and extrapolating the data.
Of course it is recommended, there has been so little progress that anything will get people’s attention. But it also only works on recurrent cancer tissue, and doesn’t have a clear explanation in terms of destroying tumor tissue.
So, whatever the case, there are many with incredible knowledge who have ongoing skepticism even as they will no doubt recommend the treatment because you always want to give hope.
And multiple governmental agencies reviewed the data and chose not to fund it for most patients because the benefits were questionable for most patients. The UK only provides it to a narrow band if patients. Washington State went through a whole breakdown.
I’ve posted this stuff before. Plus you have statistical evidence problems that Flipper has gone through in relationship to overly
censoring and extrapolating the data.
Of course it is recommended, there has been so little progress that anything will get people’s attention. But it also only works on recurrent cancer tissue, and doesn’t have a clear explanation in terms of destroying tumor tissue.
So, whatever the case, there are many with incredible knowledge who have ongoing skepticism even as they will no doubt recommend the treatment because you always want to give hope.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
